Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses - PubMed (original) (raw)
Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses
Y A Hannun et al. Science. 1987.
Abstract
Lysosphingolipids potently and reversibly inhibited protein kinase C activity and binding of phorbol dibutyrate in vitro and in human platelets. As with activation of protein kinase C by phosphatidylserine and sn-1,2-diacylglycerol, inhibition was subject to surface dilution. Accordingly, inhibition in mixed micelle assays was dependent on the molar percentage of lysosphingolipids rather than the bulk concentration. Lysosphingolipids inhibited protein kinase C activity at molar percentages similar to those required for activation by phosphatidylserine and sn-1,2-diacylglycerol. Since lysosphingolipids accumulate in Krabbe's disease, Gaucher's disease, and other sphingolipidoses, the hypothesis that lysosphingolipid inhibition of protein kinase C represents the missing functional link between the accumulation of sphingolipids and the pathogenesis of these disorders appears to unify existing data. The accumulation of lysosphingolipids would cause progressive dysfunction of signal transduction mechanisms vital for neural transmission, differentiation, development, and proliferation and would eventually lead to cell death.
Similar articles
- Regulation of protein kinase C by sphingosine and lysosphingolipids.
Hannun YA, Bell RM. Hannun YA, et al. Clin Chim Acta. 1989 Dec 15;185(3):333-45. doi: 10.1016/0009-8981(89)90224-6. Clin Chim Acta. 1989. PMID: 2695275 Review. - Apoptosis of Neuro2a cells induced by lysosphingolipids with naturally occurring stereochemical configurations.
Sueyoshi N, Maehara T, Ito M. Sueyoshi N, et al. J Lipid Res. 2001 Aug;42(8):1197-202. J Lipid Res. 2001. PMID: 11483620 - Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets.
Hannun YA, Loomis CR, Merrill AH Jr, Bell RM. Hannun YA, et al. J Biol Chem. 1986 Sep 25;261(27):12604-9. J Biol Chem. 1986. PMID: 3462188 - Evaluation of synthetic sphingosine, lysosphingolipids and glycosphingolipids as inhibitors of functional responses of human neutrophils.
Fiore S, Nicolaou KC, Caulfield T, Kataoka H, Serhan CN. Fiore S, et al. Biochem J. 1990 Feb 15;266(1):25-31. doi: 10.1042/bj2660025. Biochem J. 1990. PMID: 2155608 Free PMC article. - Potential Role of Sphingolipidoses-Associated Lysosphingolipids in Cancer.
Dubot P, Astudillo L, Therville N, Carrié L, Pettazzoni M, Cheillan D, Stirnemann J, Levade T, Andrieu-Abadie N, Sabourdy F. Dubot P, et al. Cancers (Basel). 2022 Oct 5;14(19):4858. doi: 10.3390/cancers14194858. Cancers (Basel). 2022. PMID: 36230781 Free PMC article. Review.
Cited by
- Integrated bulk and single-cell profiling characterize sphingolipid metabolism in pancreatic cancer.
Zhang B, Zhang B, Wang T, Huang B, Cen L, Wang Z. Zhang B, et al. BMC Cancer. 2024 Nov 1;24(1):1347. doi: 10.1186/s12885-024-13114-8. BMC Cancer. 2024. PMID: 39487387 Free PMC article. - Chromatographic Separation and Quantitation of Sphingolipids from the Central Nervous System or Any Other Biological Tissue.
Ray SK, Dasgupta S. Ray SK, et al. Methods Mol Biol. 2024;2761:149-157. doi: 10.1007/978-1-0716-3662-6_12. Methods Mol Biol. 2024. PMID: 38427236 - The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fc epsilon receptor I triggering.
Prieschl EE, Csonga R, Novotny V, Kikuchi GE, Baumruker T. Prieschl EE, et al. J Exp Med. 1999 Jul 5;190(1):1-8. doi: 10.1084/jem.190.1.1. J Exp Med. 1999. PMID: 10429665 Free PMC article. - The role of sphingolipids in neuronal development: lessons from models of sphingolipid storage diseases.
Buccoliero R, Bodennec J, Futerman AH. Buccoliero R, et al. Neurochem Res. 2002 Aug;27(7-8):565-74. doi: 10.1023/a:1020207613196. Neurochem Res. 2002. PMID: 12374191 Review. - Anti-tumor effect of chemically synthesized sulfolipids based on sea urchin's natural sulfonoquinovosylmonoacylglycerols.
Sahara H, Hanashima S, Yamazaki T, Takahashi S, Sugawara F, Ohtani S, Ishikawa M, Mizushina Y, Ohta K, Shimozawa K, Gasa S, Jimbow K, Sakaguchi K, Sato N, Takahashi N. Sahara H, et al. Jpn J Cancer Res. 2002 Jan;93(1):85-92. doi: 10.1111/j.1349-7006.2002.tb01204.x. Jpn J Cancer Res. 2002. PMID: 11802812 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials